PT Kalbe Farma Tbk. (PTKFF)
OTCMKTS · Delayed Price · Currency is USD
0.0626
-0.0332 (-34.66%)
At close: Sep 3, 2025
PT Kalbe Farma Tbk. Market Cap
PT Kalbe Farma Tbk. has a market cap or net worth of $3.28 billion as of September 18, 2025. Its market cap has decreased by -32.13% in one year.
Market Cap
3.28B
Enterprise Value
3.20B
Revenue
2.06B
Ranking
n/a
PE Ratio
15.61
Stock Price
$0.06
Market Cap Chart
Since February 26, 1992, PT Kalbe Farma Tbk.'s market cap has increased from 96.30M to 3.28B, an increase of 3,306.54%. That is a compound annual growth rate of 11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 3.28B | -15.66% |
| Dec 30, 2024 | 3.89B | -19.49% |
| Dec 29, 2023 | 4.83B | -22.39% |
| Dec 30, 2022 | 6.23B | 17.30% |
| Dec 30, 2021 | 5.31B | 7.29% |
| Dec 30, 2020 | 4.95B | -9.36% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 718.26M |
| Tian'an Technology Group | 609.94M |
| Glass House Brands | 567.62M |
| Northwest Biotherapeutics | 378.51M |
| CytoDyn | 377.06M |
| American Oncology Network | 345.48M |